Cliff Asness's TRVI Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 29,202 shares of Trevi Therapeutics, Inc. (TRVI) worth $365,608, representing 0.00% of the portfolio. First purchased in 2024-Q4, this short-term holding has been held for 5 quarters.
Based on 13F filings, Cliff Asness has maintained this position in TRVI for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 17,980 shares. Largest reduction occurred in Q4 2025, reducing 13,608 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Trevi Therapeutics (TRVI) Holding Value Over Time
Track share changes against reported price movement
Quarterly Trevi Therapeutics (TRVI) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -13,608 | Reduce 31.79% | 29,202 | $12.52 |
| Q3 2025 | +17,980 | Add 72.41% | 42,810 | $9.15 |
| Q2 2025 | -2,890 | Reduce 10.43% | 24,830 | $5.47 |
| Q1 2025 | +4,688 | Add 20.35% | 27,720 | $6.29 |
| Q4 2024 | +23,032 | New Buy | 23,032 | $4.12 |
Cliff Asness's Trevi Therapeutics Investment FAQs
Cliff Asness first purchased Trevi Therapeutics, Inc. (TRVI) in Q4 2024, acquiring 23,032 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Trevi Therapeutics, Inc. (TRVI) for 5 quarters since Q4 2024.
Cliff Asness's largest addition to Trevi Therapeutics, Inc. (TRVI) was in Q4 2024, adding 23,032 shares worth $94,892.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 29,202 shares of Trevi Therapeutics, Inc. (TRVI), valued at approximately $365,608.
As of the Q4 2025 filing, Trevi Therapeutics, Inc. (TRVI) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Trevi Therapeutics, Inc. (TRVI) was 42,810 shares, as reported at the end of Q3 2025.